Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS3006 in Advanced Solid Tumors
NCT03516123Phase 1Completed
- Sponsor
- CStone Pharmaceuticals
- Start
- Jun 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cs3006 in solid tumor, sponsored by CStone Pharmaceuticals. Primary endpoint: Number of participants with adverse events. Started Jun 2018; status: completed.
02
Drugs
cs3006
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03516123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03516123.